Viewing Study NCT03450850


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-05 @ 7:33 PM
Study NCT ID: NCT03450850
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-16
First Post: 2018-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma
Sponsor: Daniela A. Bota
Organization: